BofA Raises Hims & Hers Target to $25 as FDA Takes a Step Toward Wellness Peptides: Is a New Revenue Boom Coming?

Yahoo Finance·Apr 16

This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

BofA raises Hims and Hers stock price target to $37 on growth

Investing.com·Jul 9

2

BofA raises Hims and Hers stock price target on FDA peptide review

Investing.com·Jul 1

3

Bank of America resets Hims and Hers stock price target

thestreet.com·Apr 27

4

HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030

Yahoo Finance·Jun 16

5

Hims & Hers targets lifted as sales growth accelerates

scanx.trade·Jul 1

6

BofA raises Hims and Hers stock price target on Lilly partnership

Investing.com·Apr 23

7

Hims stock price reacts strongly to crucial FDA review

Yahoo Finance·Apr 23

8

HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish

Stocktwits·Jul 1